Juan Graham is CFO at FIBROGEN INC (FGEN). They have made 4 open-market trades across 2 companies since 2022, most recently 2025-03-28.
CIK 0001879223
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $150K since 2025, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CATX | BUY | 2025-03-28 | 2025-04-01 | $2.25 | $150K | -4.4% | +21.1% | +68.6% |
| FGEN | SELL | 2023-06-07 | 2023-06-09 | $16.99 | $30K | -2.4% | -83.7% | -94.2% |
| FGEN | SELL | 2023-03-08 | 2023-03-10 | $20.71 | $216K | -6.2% | -3.2% | -10.3% |
| FGEN | SELL · 10b5-1 | 2022-12-09 | 2022-12-14 | $14.90 | $12K | +3.7% | +39.6% | +36.6% |
| FGEN | SELL · 10b5-1 | 2022-12-09 | 2022-12-15 | $14.64 | $32K | +6.7% | +37.6% | +39.5% |
| FGEN | SELL | 2022-12-08 | 2022-12-15 | $14.87 | $164K | +6.7% | +37.6% | +39.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.